152 related articles for article (PubMed ID: 29795564)
1. Expression and clinical significance of survivin in ovarian cancer: A meta-analysis.
He X; Yang K; Wang H; Chen X; Wu H; Yao L; Ma S
PLoS One; 2018; 13(5):e0194463. PubMed ID: 29795564
[TBL] [Abstract][Full Text] [Related]
2. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
Cheng KY; Wang ZL; Gu QY; Hao M
PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of survivin and its underlying mechanism in ovarian cancer: A bioinformatics study based on GEO and TCGA data mining.
Li XJ; Pang JS; Li YM; Ahmed FA; He RQ; Ma J; Ma FC; Chen G
Pathol Res Pract; 2018 Mar; 214(3):385-401. PubMed ID: 29499854
[TBL] [Abstract][Full Text] [Related]
5. EVALUATION THE EXPRESSION OF THREE GENES TO EPITHELIAL OVARIAN CANCER RISK IN CHINESE POPULATION.
Huang J; Lin H; En Lin M
Afr J Tradit Complement Altern Med; 2016; 13(4):81-87. PubMed ID: 28852723
[TBL] [Abstract][Full Text] [Related]
6. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
Ma C; Lu B; Sun E
Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.
Gąsowska-Bajger B; Gąsowska-Bodnar A; Knapp P; Bodnar L
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669912
[TBL] [Abstract][Full Text] [Related]
10. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
Duan L; Hu X; Jin Y; Liu R; You Q
BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
12. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
Xiong C; Liu H; Chen Z; Yu Y; Liang C
Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
[TBL] [Abstract][Full Text] [Related]
14. The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis.
Gao S; Zhang W; Yan N; Li M; Mu X; Yin H; Wang J
J Ovarian Res; 2021 Nov; 14(1):164. PubMed ID: 34789292
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis.
Geng J; Lei YR; Pei SG
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):965-973. PubMed ID: 29270761
[TBL] [Abstract][Full Text] [Related]
17. Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.
Jiang M; Lin X; He R; Lin X; Liang L; Tang R; Xiong D; Wei K; Dang Y; Feng Z; Chen G
Med Sci Monit; 2016 Jun; 22():1850-7. PubMed ID: 27246752
[TBL] [Abstract][Full Text] [Related]
18. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
[TBL] [Abstract][Full Text] [Related]
19. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
Si JG; Su YY; Han YH; Chen RH
Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer.
Zhou Q; Huang F; He Z; Zuo MZ
Climacteric; 2018 Feb; 21(1):60-68. PubMed ID: 29231068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
